Frank Michael Horling
Frank Michael Horling publishes mostly in Hematology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Hemophilia Treatment and Research, Platelet Disorders and Treatments and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #3,344,893 of 7,710,434 ranked researchers
- Rank in Austria
- #20,172 of 43,330
- Works
- 28
- Citations
- 847
- Citations per work
- 30.3
What does Frank Michael Horling research?
Frank Michael Horling's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1760.1%
- Medicine1760.1%
- Life Sciences931.4%
- Everything else28.5%
- 1Hematology44% of their works
- 2Molecular Biology16% of their works
- 3Radiology, Nuclear Medicine and Imaging12% of their works
- 4Immunology9% of their works
- 5Genetics6% of their works
- 6Genetics4% of their works
Research topics
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Monoclonal and Polyclonal Antibodies Research
- Biosimilars and Bioanalytical Methods
- Virus-based gene therapy research
- Blood Coagulation and Thrombosis Mechanisms
- Viral Infectious Diseases and Gene Expression in Insects
- Protein purification and stability
Which keywords describe Frank Michael Horling's research?
The keywords of their largest research topics: Gene Therapy, Monoclonal Antibodies, Factor VIII, Hemophilia, Hemostasis, Inflammation, Glycosylation and Therapeutic Antibodies.
- Recombinant Proteins
- Protein Aggregation
- Viral Vectors
- Protease-Activated Receptors
- Biosimilars
- Immunogenicity
- Fc Receptors
- Thrombosis
- Therapeutic Antibodies
- Inflammation
- Hemophilia
- Monoclonal Antibodies
- Gene Therapy
- Factor VIII
- Hemostasis
- Glycosylation
- Platelets
- Antibody Engineering
- Biopharmaceuticals
- Bioanalytical Methods
- AAV
- Thrombin
- Mammalian Cells
- Recombinant Protein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Gene Therapy192 topics
- Monoclonal Antibodies173 topics
- Factor VIII151 topic
- Hemophilia151 topic
- Hemostasis142 topics
- Inflammation142 topics
- Glycosylation122 topics
- Therapeutic Antibodies122 topics
- Platelets101 topic
- Thrombosis101 topic
- Antibody Engineering91 topic
- Fc Receptors91 topic
- Biopharmaceuticals82 topics
- Immunogenicity82 topics
- Bioanalytical Methods51 topic
- Biosimilars51 topic
- AAV41 topic
- Protease-Activated Receptors41 topic
- Thrombin41 topic
- Viral Vectors41 topic
- Mammalian Cells31 topic
- Protein Aggregation31 topic
- Recombinant Protein31 topic
- Recombinant Proteins31 topic
Where does Frank Michael Horling work?
Frank Michael Horling's main affiliation in the publication record is Baxter (Austria), Austria.
How many publications and citations does Frank Michael Horling have?
OpenAlex counts 28 works and 847 citations for Frank Michael Horling, an h-index of 10, ranking #3,344,893 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Frank Michael Horling. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.